Home › Overweight › Iowa
Pag-aaral pangklinika para sa Overweight sa Iowa
9 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa Iowa.
Mga Lungsod sa Iowa
Opisyal na teksto ng pag-aaral (English)
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Iowa Diabetes and Endocrinology Research Center, West Des Moines
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Iowa Diabetes and Endocrinology Research Center, West Des Moines
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- McFarland Clinic PC, Ames
- Midwest Cardiovascular Research Foundation, Davenport
Nagre-recruitPhase 3
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Iowa Diabetes and Endocrinology Research Center, West Des Moines
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07321886A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Des Moines
- ACCOMPLISH-2 Research Site, Iowa City
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Iowa Diabetes and Endocrinology Research Center, West Des Moines
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06143956Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Iowa Diabetes Research, West Des Moines
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684144A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Ames
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07784725Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Iowa City
Nagre-recruitPhase 3
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361Mula sa ClinicalTrials.gov, na-kuha noong Okt 4, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.